Eradicatus Infectus Private Limited - Due diligence report

A 360° intelligence report on Genestore: trust score, financial health, credit view, compliance, directors, growth and distress signals - ge…

2019-12-04 New Delhi, Delhi Active Unlisted Active Compliant
Share
Connect MCP
EI Eradicatus Infectus Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Genestore — 360° Intelligence Report

Generated from MCA filings & public records
59/100
Trust Score
Moderate

Genestore is assessed as Moderate with a Trust Score of 59/100. Genestore is an active private limited indian non-government company incorporated in 2019, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.

Report generated on 14 Aug 2026 from the latest processed filings. Eradicatus Infectus Private Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
59/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
71/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
40/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Working-capital cover adequate.

Charges position: 1 open (9.80 Lakh) · 1 satisfied (95.86 Lakh).

Banking relationships (from registered charges)
LenderChargesAmount
Axis Bank Limited1 48.0 cr
Others1 48.0 cr
Compliance Score: 71/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 1 court forum(s).
  • 1 auditor resignation(s) filed - latest: ANUJ DUA & COMPANY on 2021-12-22.
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 40/100
NameDIN / PANDesignationAppointedTenureDIN status
PREETI TANK 01234567 Director 01/04/2018 6 yrs Approved
ANUBHAV ANUSHA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • ANUBHAV ANUSHA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • 2 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
2
Group entities
2
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Pathstore Dx Rx India Private Limited Subsidiary Company 74.00%
Franco Alliance Private Limited Subsidiary Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 60
Growth signals & trust indicators
Steady revenue growth: +38% over 4 year(s).
Operating for 6 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
1 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence64/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment50/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 9.80 Lakh already registered.
  • Compliance record supports lending.
Investor view53/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 10 events
22 Sep 2025
Director ceased
ANUBHAV ANUSHA
18 Jul 2025
Director appointed
ANUBHAV ANUSHA (Director)
Director ceased
MANAVI ANUSHA
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
15 Jan 2024
Charge satisfied
Axis Bank Limited
22 Dec 2023
Charge created
Others - 9.80 Lakh
26 Aug 2022
Charge created
Axis Bank Limited - 95.86 Lakh
04 Dec 2019
Incorporated
Registered with Roc Delhi
Director appointed
PREETI TANK (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Net worth is positive.
2 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 2 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Dhcd Private Limited U93090KA2020PTC139591 Bangalore, Karnataka, India
Kauvery Health Enterprises Private Limited U74900TN2015PTC102457 Trichy, Tamil Nadu, India
Threos Healthcare Private Limited U24303TN2019PTC127638 Sriperumbudur, Tamil Nadu, India
Cosmic Fortunes India Limited U33112TG1999PLC032421 Hyderabad, Telangana, India
Araya Health Private Limited U24230KA2022PTC160155 Bengaluru, Karnataka, India
Dolphin Medical Services Ltd L24239TG1992PLC014775 Seri Lingampally, Telangana, India
Newmi U85300HR2021PTC096690 Gurgaon, Haryana, India
Elda Health U72900KA2020PTC131849 Bangalore South, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Genestore before audits and certifications: compliance score 71/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Genestore: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 60/100, margin trends, ownership structure and peer set for Genestore - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 59/100, distress signals and MSME payment-delay disclosures - know whether Genestore pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Genestore - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Genestore an active company?

Genestore has MCA status “Active” with a compliance score of 71/100 (Moderate).

Is Genestore financially healthy?

Genestore has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Genestore?

Its overall Trust Score is 59/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Genestore?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Genestore have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Genestore up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 71/100 (Moderate).

Is it risky to lend to Genestore?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.